# A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

> **NCT00912093** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 98 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** Icatibant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00912093
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-16
- **Primary completion:** 2010-10-01
- **Final completion:** 2010-10-01
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00912093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00912093, "A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00912093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*